Conmed

Conmed Rule of 40

The Rule of 40 of Conmed (CNMD) as of Nov 5, 2026 is 12.60 %. In the previous year, Rule of 40 was 20.33 % — a change of -38.03% (lower).

Rule of 40

12.60 %

YoY

-38.03%

Last updated:

Rule of 40 of Conmed is 2025 12.60 % . Rule of 40 of Conmed was 2024 20.33 % . It decreases by -38.03% lower compared to the previous year.

The Conmed Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
16.24 USD
Jan 1, 2019
19.39 USD
Jan 1, 2020
-4.36 USD
Jan 1, 2021
27.93 USD
Jan 1, 2022
10.15 USD
Jan 1, 2023
28.75 USD
Jan 1, 2024
20.33 USD
Jan 1, 2025
12.60 USD
The Conmed Rule of 40 history
YEARRule of 40YoY
12.60 %-38.03%
20.33 %-29.29%
28.75 %+183.31%
10.15 %-63.66%
27.93 %-739.82%
-4.36 %-122.51%
19.39 %+19.42%
16.24 %+59.19%
10.20 %-8.13%
11.10 %+120.58%
5.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Conmed Stock analysis

What does Conmed do? Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Conmed stock

Rule of 40 of Conmed is 12.60 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Conmed since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Conmed

All Key Metrics — Conmed